Aastrom buys Sanofi's cell therapy and regenerative medicine business for $6.5mm
Sanofi sold its Cell Therapy and Regenerative Medicine (CTRM) business to Aastrom Biosciences Inc. (multicellular therapies for cardiovascular diseases) for a total of $6.5mm ($4mm in cash and the rest in a promissory note).
- Gene Therapy, Cell Therapy
- Large Molecule
- Full Acquisition
- Payment Includes Cash for Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.